Platinum compounds for binding guanine quadruplexes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11492366
APP PUB NO 20210188889A1
SERIAL NO

16761310

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds are described and characterized that bind guanine quadruplexes of DNA or RNA. Binding data and inhibition of growth data of five cancer cell lines are presented.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC CEDEX 13 PARIS 75654

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Mergny, Jean-Louis Pessac, FR 23 28
Miron, Caitlin Montreal, CA 1 0
Petitjean, Anne Kingston, CA 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 May 8, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 May 8, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 8, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00